US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

106.38

+0.87000.82%

Volume:8.18M

Turnover:867.03M

Market Cap:132.62B

PE:279.95

High:106.64

Open:105.95

Low:99.32

Close:105.51

Loading ...

Overview Company News Filings

BUZZ-Gilead slides as Trump administration puts HIV prevention funds under review

Positive Outlook on Gilead Sciences Amidst Funding Uncertainty and Growing PrEP Support

These Stocks Are Moving the Most Today: Nvidia, Tesla, Autodesk, Gilead Sciences, HealthEquity, General Mills, and More -- Barrons.com

Positive Outlook for Gilead Sciences Amid Funding Concerns and Growth Opportunities

INCY Stock Down on Disappointing Skin Disease Study Data

Is Gilead Sciences, Inc. (GILD) a Best Biotech Stock According to Billionaires?

GILD Stock Trading Close to Its 52-Week High: Should You Buy or Sell?

AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies

Is Gilead Sciences, Inc. (GILD) The Most Undervalued NASDAQ Stock To Buy According To Hedge Funds?

Why Is Biogen (BIIB) Up 1.1% Since Last Earnings Report?

Why Gilead Sciences, Inc. (GILD) is the Best Pharma Stock to Buy According to Hedge Funds

GILD vs. VRTX: Which Stock Is the Better Value Option?

Gilead (GILD) Up 10.3% Since Last Earnings Report: Can It Continue?

Bernstein Reaffirms Their Buy Rating on Gilead Sciences (GILD)

These 3 Attractive Stocks Keep Cruising Higher

Gilead Sciences Once-yearly HIV Prevention Treatment Safe, Well Tolerated in Study

MT Newswires Live

NVO Stock Down 9% as CagriSema Misses Target in Second Obesity Study

BRIEF-Gilead Sciences Presents First Clinical Data For Investigational Once-Yearly Lenacapavir For HIV Prevention

Gilead Sciences: Data Shows Promising Once-Yearly Lenacapavir for Prep Pharmacokinetic Profiles Over 52 Weeks

THOMSON REUTERS

Gilead Sciences: New Study Population Data From Purpose 1 Show Comparable Pharmacokinetic & Safety Profilesfor Adolescent & Adult Trial Participants

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GILD/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GILD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"Gilead Sciences","latestPrice":106.38,"timestamp":1745438400000,"preClose":105.51,"halted":0,"volume":8178745,"delay":0,"floatShares":1243965050,"shares":1246634469,"eps":0.38,"marketStatus":"Pre-Mkt","change":0.87,"latestTime":"04-24 04:33:56 EDT","open":105.95,"high":106.635,"low":99.32,"amount":867030556.7739,"amplitude":0.06933,"askPrice":106.69,"askSize":7,"bidPrice":106.32,"bidSize":7,"shortable":3,"etf":0,"ttmEps":0.38,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745501400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":696056400000,"exchange":"NASDAQ","adjPreClose":106.38,"dividendRate":0.028953,"postHourTrading":{"tag":"盘后","latestPrice":106.5699,"preClose":106.41,"latestTime":"19:59 EDT","volume":608265,"amount":64707953.2899,"timestamp":1745452771324},"volumeRatio":1.1045835989819988,"optionData":{"bulkOrders":[{"symbol":"GILD","call":false,"expireDate":1747368000000,"strike":"80.0","timestamp":1745430169395,"price":0.2,"volume":1570,"amount":31400,"type":"+"}]},"impliedVol":0.4002,"impliedVolPercentile":0.9438},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","floatShares":1243965050,"roa":"11.03%","roe":"2.29%","lyrEps":0.384923,"volumeRatio":1.1045835989819988,"shares":1246634469,"dividePrice":3.08,"high":106.635,"amplitude":0.06933,"preClose":105.51,"low":99.32,"week52Low":62.07,"pbRate":"6.86","psRate":"4.61","week52High":119.96,"institutionHeld":0.7997,"latestPrice":106.38,"eps":0.38,"divideRate":0.028953,"volume":8178745,"delay":0,"ttmEps":0.38,"open":105.95,"prevYearClose":92.37,"prevWeekClose":104.54,"prevMonthClose":112.05,"prevQuarterClose":112.05,"fiveDayClose":105.68,"twentyDayClose":107.89,"sixtyDayClose":95.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GILD\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520908632","title":"BUZZ-Gilead slides as Trump administration puts HIV prevention funds under review","url":"https://stock-news.laohu8.com/highlight/detail?id=2520908632","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520908632?lang=en_us&edition=fundamental","pubTime":"2025-03-19 18:26","pubTimestamp":1742380014,"startTime":"0","endTime":"0","summary":"BUZZ-Gilead slides as Trump administration puts HIV prevention funds under review ** Shares of Gilead Sciences GILD.O fall ~3% to $107 premarket** U.S. health department is reviewing CDC's HIV prevent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nL4N3Q20TE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","SG9999015358.SGD","IE00B19Z3B42.SGD","IE00BJJMRZ35.SGD","IE00BN8TJ469.HKD","LU1023059063.AUD","SG9999015341.SGD","LU1934455194.USD","LU0889565916.HKD","LU1291159041.SGD","IE00B2B36J28.USD","LU0965509283.SGD","LU1929549753.HKD","IE00B7SZLL34.SGD","LU0203347892.USD","LU2023250843.SGD","SG9999002224.SGD","GILD","SG9999014542.SGD","LU0861579265.USD","LU0265550359.USD","BK4566","LU1571399168.USD","LU2106854487.HKD","SG9999014567.USD","BK4139","BK4534","LU2361044949.HKD","BK4532","LU1116320737.USD","LU1035773651.USD","LU1116320901.HKD","LU1989771016.USD","IE00BJT1NW94.SGD","LU0320765489.SGD","LU0265550946.USD","LU0320765646.SGD","SG9999002232.USD","LU2324357040.USD","LU0211331839.USD","LU1066053197.SGD","LU1057294990.SGD","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU0203345920.USD","LU1066051498.USD","MRK","IE00B3T34201.USD","LU2361045086.USD","LU1941712348.USD"],"gpt_icon":0},{"id":"2520908506","title":"Positive Outlook on Gilead Sciences Amidst Funding Uncertainty and Growing PrEP Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2520908506","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520908506?lang=en_us&edition=fundamental","pubTime":"2025-03-19 18:17","pubTimestamp":1742379440,"startTime":"0","endTime":"0","summary":"Analyst Terence Flynn from Morgan Stanley maintained a Buy rating on Gilead Sciences (GILD – Research Report) and keeping the price target at $130....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-on-gilead-sciences-amidst-funding-uncertainty-and-growing-prep-support?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-on-gilead-sciences-amidst-funding-uncertainty-and-growing-prep-support?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU1989772840.SGD","LU0320765646.SGD","LU0971096721.USD","LU2347655156.SGD","LU0314104364.USD","LU0106261372.USD","LU0795875086.SGD","BK4534","BK4566","IE00B3T34201.USD","IE00BSNM7G36.USD","LU0106831901.USD","LU0098860793.USD","LU2089984988.USD","LU0109394709.USD","IE00BZ1G4Q59.USD","BK4127","BK4583","LU0158827781.USD","IE0002270589.USD","BK4532","LU0912757837.SGD","BK4504","IE00B19Z3B42.SGD","LU2089283258.USD","LU0795875169.SGD","LU0158827948.USD","LU1430594728.SGD","LU1363072403.SGD","LU1162221912.USD","BK4588","LU2023251221.USD","GILD","LU1548497426.USD","BK4585","LU2468319806.SGD","LU0889565916.HKD","LU2087621335.USD","LU0225283273.USD","LU2271345857.HKD","LU2028103732.USD","LU1720051017.SGD","BK4516","LU1732800096.USD","LU2357305700.SGD","LU0320765992.SGD","LU1585245621.USD","BK4550","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2520771039","title":"These Stocks Are Moving the Most Today: Nvidia, Tesla, Autodesk, Gilead Sciences, HealthEquity, General Mills, and More -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2520771039","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520771039?lang=en_us&edition=fundamental","pubTime":"2025-03-19 18:10","pubTimestamp":1742379000,"startTime":"0","endTime":"0","summary":"Stock futures were up modestly with Wall Street expecting the Federal Reserve on Wednesday to hold interest rates steady. The U.S. central bank's announcement on rates will be made at 2 p.m. Eastern time.Nvidia rose 1.4% in premarket trading after CEO Jensen Huang, at the chip maker's annual AI GTC conference on Tuesday, announced a more powerful version of its Blackwell AI chips, two AI desktop computers, an expanded autonomous-driving partnership with General Motors, and new AI models for robots. Nvidia shares fell 3.4% on Tuesday, the second day of Nvidia's conference, and were the session's worst performer in the Dow Jones Industrial Average. GM, meanwhile, slipped 0.3% in premarket trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"c0b34c06e0677a922ec4344893e363cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVD","LU0943347566.SGD","HQY","NVD3.UK","TSLL","NVDS","NVDY","TSYW.SI","LU0048584097.USD","LU1868836757.USD","ADSK","LU2125910179.SGD","GILD","IE00B19Z8X17.USD","IE0004445239.USD","NVD2.UK","NVDA","LU0964807845.USD","SNVD.UK","2NVD.UK","IE00BJJMRY28.SGD","IE00BKPKM429.USD","LU0215105999.USD","IE00B7KXQ091.USD","SG9999015952.SGD","LU1280957306.USD","LU2462157665.USD","LU2125909916.SGD","LU1674673428.USD","3NVD.UK","IE00BMPRXR70.SGD","NVIW.SI","TSLA","LU2458330243.SGD","LU2168564495.EUR","LU2750360997.AUD","BK4592","LU0353189680.USD","LU1868836914.USD","NVDD","NVDS.UK","NVDU","LU2360106780.USD","LU2168564149.EUR","IE00BJTD4V19.USD","GIS","LU2065171311.SGD"],"gpt_icon":1},{"id":"2520839977","title":"Positive Outlook for Gilead Sciences Amid Funding Concerns and Growth Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2520839977","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520839977?lang=en_us&edition=fundamental","pubTime":"2025-03-19 17:56","pubTimestamp":1742378164,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Chris Schott has maintained their bullish stance on GILD stock, giving a Buy rating yesterday. Chris Schott has given his Buy r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-for-gilead-sciences-amid-funding-concerns-and-growth-opportunities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-for-gilead-sciences-amid-funding-concerns-and-growth-opportunities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4578","BK4532","BK4583","IE00B19Z3581.USD","LU2087621335.USD","LU1162221912.USD","BK4139","LU1074936037.SGD","LU1989772840.SGD","IE00B19Z3B42.SGD","LU1989772923.USD","LU1571399168.USD","BK4588","LU0289739699.SGD","LU0314104364.USD","LU1668664300.SGD","LU2468319806.SGD","BK4581","BK4566","LU0158827781.USD","LU1732799900.SGD","LU2089284900.SGD","LU0158827948.USD","LU0106261372.USD","LU1720051017.SGD","IE00B7SZLL34.SGD","LU0320765646.SGD","IE0002270589.USD","LU0006306889.USD","BK4127","LU2028103732.USD","LU2023251221.USD","LU2347655156.SGD","GILD","LU0889565916.HKD","LU1548497426.USD","LU1430594728.SGD","LU2089984988.USD","LU1363072403.SGD","BK4568","LU2357305700.SGD","LU0795875086.SGD","LU1066053197.SGD","LU0971096721.USD","LU0320765992.SGD","LU0106831901.USD","LU1585245621.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2520089932","title":"INCY Stock Down on Disappointing Skin Disease Study Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2520089932","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520089932?lang=en_us&edition=fundamental","pubTime":"2025-03-19 03:00","pubTimestamp":1742324400,"startTime":"0","endTime":"0","summary":"Shares of Incyte INCY were down 8.62% on Monday after the announcement of data from two late-stage studies on an oral small-molecule JAK1 inhibitor, povorcitinib, for the treatment of hidradenitis suppurativa .HS, a chronic inflammatory skin condition, is characterized by painful nodules and abscesses.While both the late studies STOP-HS1 and STOP-HS2 studies met their primary endpoint, the results lagged investor expectations, and consequently, shares declined.Povorcitinib is an oral small-molecule JAK1 selective inhibitor currently in phase III studies for HS, vitiligo and prurigo nodularis , as well as phase II trials for asthma and chronic spontaneous urticaria .The phase III studies STOP-HS1  and STOP-HS2  are evaluating the efficacy and safety of povorcitinib in adult patients with moderate to severe HS. Both studies include a 12-week double-blind, placebo-controlled treatment period, followed by a 42-week extension period and 30-day safety follow-up.Data from the STOP-HS2 study s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incy-stock-down-disappointing-skin-190000520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0058720904.USD","LU1829250122.USD","BK4583","LU2468319806.SGD","IE00BSNM7G36.USD","BK4563","LU1066053197.SGD","IE00B3T34201.USD","GSK.UK","GSK","LU0889565916.HKD","BK4503","IE00BKVL7J92.USD","INCY","LU1066051498.USD","LU1169590202.USD","LU1430594728.SGD","BMRN","BK4214","BK4532","BK4139","AN","BK4568","LU0234570918.USD","LU1169589451.USD","LU2089984988.USD","IE0002270589.USD","BK4166","GILD","BK4585","LU0109394709.USD","PN","QD","IE00B19Z3581.USD","BK4007","BK4578","LU0289739699.SGD","BK4588","LU1585245621.USD","IE00B19Z3B42.SGD","BK4566","IE00B7SZLL34.SGD","LU1839511570.USD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","BK4550","LU0320765992.SGD"],"gpt_icon":0},{"id":"2520463599","title":"Is Gilead Sciences, Inc. (GILD) a Best Biotech Stock According to Billionaires?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520463599","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520463599?lang=en_us&edition=fundamental","pubTime":"2025-03-18 07:38","pubTimestamp":1742254731,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Gilead Sciences, Inc.  stands against other biotech stocks.Although biotech stocks had a “challenging” year in 2024, JPMorgan believes that some of the industry’s companies could see significant growth in the months to come. Senior partner and principal of investments at Novo Holdings, Johan Hueffer, spoke on CNBC on November 28 about his macro outlook for life sciences investments. He claimed that in the past few years, biotechs have had trouble raising funding. Over the past quarter or two, though, that tendency has begun to improve.Flood’s report also emphasized how the biotech sector has recently demonstrated better fundamentals, which have been ascribed to superior clinical outcomes and a more favorable regulatory environment. Goldman’s data shows that hedge funds continue to underinvest in biotechnology despite these tailwinds. Over the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-inc-gild-best-233851306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4552","GILD","LU1791807156.HKD","LU1868836591.USD","USAW.SI","US5Y.BOND","LU2750360997.AUD","US3Y.BOND","IE00B7SZLL34.SGD","BK4578","LU0889565916.HKD","TQQQ","LU2471134796.USD","MNQmain","US10Y.BOND","IE0034235188.USD","LU2750360641.GBP","BK4532","NQmain","BK4585","IE00B19Z3B42.SGD","LU0058720904.USD","LU2087621335.USD","USJW.SI","LU1066053197.SGD","QID","LU0061475181.USD",".IXIC","LU0234570918.USD","BK4516","QLD","TSYW.SI","PSQ","IE0004091025.USD","NVIW.SI","IE0004086264.USD","US30Y.BOND","BK4139","US7Y.BOND","LU1585245621.USD","US2Y.BOND","FOMC","US6M.BOND","IE00B3T34201.USD","SQQQ","US12M.BOND","IE00BKVL7J92.USD","LU1571399168.USD","LU1868837136.USD"],"gpt_icon":1},{"id":"2520686466","title":"GILD Stock Trading Close to Its 52-Week High: Should You Buy or Sell?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520686466","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520686466?lang=en_us&edition=fundamental","pubTime":"2025-03-18 03:00","pubTimestamp":1742238000,"startTime":"0","endTime":"0","summary":"Gilead Sciences, Inc. GILD hit a 52-week high of $119.96 on March 10. The stock is currently trading at $111.44.Shares have also gained 5.5% in the past month compared with the industry’s growth of 1.2%. The stock has outperformed the sector and the S&P 500 Index in this timeframe. Positive data readouts and encouraging pipeline progress have boosted investors’ sentiment.Gilead has a market-leading portfolio of HIV treatments. The company’s consistent efforts to develop additional innovative HIV treatments are being appreciated by investors.GILD’s HIV franchise sales have consistently grown in the last three years, propelling the top line.With a market share of more than 50% in the United States at the end of the fourth quarter, its flagship HIV therapy Biktarvy continues to fuel sales.The candidate was approved under the brand name Livdelzi. In March 2024, GILD acquired CymaBay Therapeutics Inc. for $4.3 bil","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gild-stock-trading-close-52-190000459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B4R5TH58.HKD","IE00BBT3K403.USD","BK4139","LU1066053197.SGD","LU0965509283.SGD","LU2461242641.AUD","IE00BLSP4452.SGD","BK4568","IE000M9KFDE8.USD","LU1989771016.USD","GSK.UK","MRK","IE00B3T34201.USD","LU1061106388.HKD","SG9999014575.USD","LU2089984988.USD","LU0109394709.USD","LU0861579265.USD","LU1929549753.HKD","IE00BFTCPJ56.SGD","PBC","IE0002270589.USD","LU1917777945.USD","LU0266013472.USD","LU0265550359.USD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4007","IE00B19Z3B42.SGD","LU0203347892.USD","LU1430594728.SGD","SG9999015358.SGD","LU1974910355.USD","LU0238689110.USD","IE00B7SZLL34.SGD","LU2361044949.HKD","GILD","LU1983299246.USD","LU0122379950.USD","LU0234570918.USD","LU1829250122.USD","LU1571399168.USD","LU1699723380.USD","LU0965508806.USD","GSK","LU0058720904.USD","SG9999001440.SGD","SG9999001176.SGD","LU1585245621.USD","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"2520576748","title":"AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2520576748","media":"Zacks","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520576748?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:38","pubTimestamp":1742218680,"startTime":"0","endTime":"0","summary":"AstraZenecaAZN announced that it has entered into a definitive agreement to acquire EsoBiotec for developing in vivo cell therapies for multiple cancer indications or immune-mediated diseases. EsoBiotec is a biotechnology company specializing in “in vivo” cell therapies with promising early clinical results.The acquisition will integrate EsoBiotec’s proprietary ENaBL platform, which empowers the immune system’s ability to target cancers, into AstraZeneca’s portfolio. This technology has the potential to expand patient access to transformative cell therapy treatments, delivering results in minutes instead of the current weeks-long process. The deal will allow EsoBiotec to leverage AZN’s vast resources and expertise in cell therapies to accelerate the development of their in vivo platform which has a novel delivery technology that is expected to have broad therapeutic applicability.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azn-acquire-esobiotec-1b-develop-133800753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1430594728.SGD","LU1559883803.SGD","LU2456880835.USD","LU2462157665.USD","LU1585245621.USD","LU0889565916.HKD","LU0058720904.USD","BK4588","LU2417539215.USD","LU2087621335.USD","BK4532","BK4568","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU0234570918.USD","IE00B19Z3581.USD","LU0289739699.SGD","LU2236285917.USD","AZN","LU0109394709.USD","CORT","GILD","IE00BZ1G4Q59.USD","LU2089984988.USD","LU1571399168.USD","BK4585","LU1066053197.SGD","IE00B3T34201.USD","BK4566","IE0002270589.USD","LU1839511570.USD","BMRN","IE00BKVL7J92.USD","BK4007","BK4578","LU0566484027.USD","IE00B7SZLL34.SGD","BK4550","LU2468319806.SGD","LU0320765992.SGD","LU1829250122.USD","BK4139","BK4583","LU1066051498.USD"],"gpt_icon":0},{"id":"2520521161","title":"Is Gilead Sciences, Inc. (GILD) The Most Undervalued NASDAQ Stock To Buy According To Hedge Funds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520521161","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520521161?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:11","pubTimestamp":1742217080,"startTime":"0","endTime":"0","summary":"We recently published a list of 13 Most Undervalued NASDAQ Stocks To Buy According To Hedge Funds. In this article, we are going to take a look at where Gilead Sciences, Inc.  stands against other most undervalued NASDAQ stocks to buy according to hedge funds.In a turbulent market where growth stocks are tumbling and value stocks have gained, sector valuations are starting to balance out. Healthcare, real estate, and basic materials, which were undervalued at the start of 2025, have moved closer to fair value. Meanwhile, consumer cyclical stocks, previously the most overvalued,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-inc-gild-most-131120259.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889565916.HKD","NDAQ","USAW.SI","LU1571399168.USD","LU2095319765.USD","LU0109394709.USD","IE0002270589.USD","LU0320765992.SGD","QLD","LU0234570918.USD","LU2468319806.SGD","LU0058720904.USD","TQQQ","IE00B64PRP62.GBP","IE00BZ1G4Q59.USD","BK4578","LU0289739699.SGD","IE00BKPKM429.USD","BK4568","LU1066051498.USD","LU2089984988.USD","BK4139","GILD","PSQ","NVIW.SI","BK4550","BK4583","IE00B3QW5Z07.USD","LU1430594728.SGD","TSYW.SI","IE00B19Z3581.USD","BK4566","QID","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","BK4585","USJW.SI","LU2210149790.SGD","NQmain","LU1839511570.USD","LU1585245621.USD","SQQQ","BK4532","BK4588","LU1066053197.SGD","IE00BSNM7G36.USD","LU2210150020.SGD","MNQmain",".IXIC"],"gpt_icon":1},{"id":"2519438089","title":"Why Is Biogen (BIIB) Up 1.1% Since Last Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519438089","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519438089?lang=en_us&edition=fundamental","pubTime":"2025-03-14 23:30","pubTimestamp":1741966235,"startTime":"0","endTime":"0","summary":"It has been about a month since the last earnings report for Biogen Inc. . Shares have added about 1.1% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Biogen due for a pullback?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.It turns out, estimates review have trended downward during the past month.The consensus estimate has shifted -9.02% due to these changes.At this time, Biogen has a subpar Growth Score of D, however its Momentum Score is doing a bit better with a C. However, the stock was allocated a grade of A on the value side, putting it in the top 20% for this investment strategy.Biogen is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Gilead Sciences , a stock from the same industry, has gained 7%. The company reported ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-biogen-biib-1-1-153035548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIIB","GILD"],"gpt_icon":0},{"id":"2519985784","title":"Why Gilead Sciences, Inc. (GILD) is the Best Pharma Stock to Buy According to Hedge Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2519985784","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519985784?lang=en_us&edition=fundamental","pubTime":"2025-03-14 01:07","pubTimestamp":1741885676,"startTime":"0","endTime":"0","summary":"We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Gilead Sciences, Inc.  stands against the other best pharma stocks to buy according to hedge funds.Why is China the Talk of the Town in the Pharma Industry?Experts are attributing several reasons to this trend. Some believe that Chinese pharmaceutical companies are attracting attention because of their advanced development capabilities that are producing effective molecules in substantial quantities. These Chinese companies are also in a position to assign a lower price to these medicines compared to the US, and are capable of initiating their testing on human subjects quicker. According to CNBC, buyers have devised a business model allowing them to import medicines through licensing deals. Biotech companies are further pushed into making these deals due to the drying up of venture funding in China.Talking about the tariffs, she said that thei","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-gilead-sciences-inc-gild-170756149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4583","USJW.SI","BK4585","LU0889565916.HKD","LU1839511570.USD","LU0320765992.SGD","GILD","QID","LU0109394709.USD","BK4568","NVIW.SI","PSQ","IE00B3T34201.USD","LU1430594728.SGD","LU1571399168.USD","LU0058720904.USD","IE00B7SZLL34.SGD","LU0234570918.USD","BK4532","IE00BKVL7J92.USD","QLD","LU1066053197.SGD","LU2468319806.SGD","BK4578","NQmain","IE0002270589.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","IE00B19Z3581.USD","BK4550",".IXIC","LU2087621335.USD","TSYW.SI","LU2089984988.USD","BK4588","MNQmain","TQQQ","USAW.SI","BK4139","LU1066051498.USD","SQQQ","LU1585245621.USD","BK4566"],"gpt_icon":1},{"id":"2519485040","title":"GILD vs. VRTX: Which Stock Is the Better Value Option?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519485040","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519485040?lang=en_us&edition=fundamental","pubTime":"2025-03-13 23:40","pubTimestamp":1741880408,"startTime":"0","endTime":"0","summary":"Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Gilead Sciences  or Vertex Pharmaceuticals . But which of these two stocks presents investors with the better value opportunity right now?The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.Gilead Sciences and Vertex Pharmaceuticals are sporting Zacks Ranks of #2  and #3 , respectively, right now. This means that GILD's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. However, value investors will care about much more than just this.Gilead Sciences, Inc.  : Free Stock Analysis Report. Vertex Pharmaceuticals Incorporated  : Free Stock Analysis Report. Thi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gild-vs-vrtx-stock-better-154008867.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0289739699.SGD","LU2089984988.USD","LU1559883803.SGD","IE00B7SZLL34.SGD","BK4139","LU1066053197.SGD","LU1069344957.HKD","LU0256863811.USD","LU1430594728.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU2462157665.USD","LU0757428866.USD","LU2417539215.USD","BK4568","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1839511570.USD","BK4533","IE00B19Z3B42.SGD","VRTX","LU0889565916.HKD","LU1585245621.USD","IE00BZ9MQY76.HKD","LU2362541513.USD","LU0234570918.USD","LU0566484027.USD","IE00B3T34201.USD","IE0002270589.USD","LU0417517546.SGD","LU1066051498.USD","LU0320765992.SGD","LU2236285917.USD","LU2087621335.USD","BK4578","BK4588","LU2362540622.SGD","LU1093756168.USD","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","LU0079474960.USD","IE00B894F039.SGD","GILD","LU0109394709.USD","LU0823416689.USD","LU1815336091.USD","IE0002141913.USD","VERX","LU2456880835.USD","LU0061475181.USD"],"gpt_icon":1},{"id":"2519283850","title":"Gilead (GILD) Up 10.3% Since Last Earnings Report: Can It Continue?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519283850","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519283850?lang=en_us&edition=fundamental","pubTime":"2025-03-13 23:30","pubTimestamp":1741879829,"startTime":"0","endTime":"0","summary":"It has been about a month since the last earnings report for Gilead Sciences . Shares have added about 10.3% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Gilead due for a pullback?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.It turns out, estimates revision have trended downward during the past month.The consensus estimate has shifted -5% due to these changes.Gilead is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Bristol Myers Squibb , a stock from the same industry, has gained 6.5%. The company reported its results for the quarter ended December 2024 more than a month ago.Gilead Sciences, Inc.  : Free Stock Analysis Report","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-gild-10-3-since-153029337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GILD","BMY"],"gpt_icon":0},{"id":"2518058001","title":"Bernstein Reaffirms Their Buy Rating on Gilead Sciences (GILD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518058001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518058001?lang=en_us&edition=fundamental","pubTime":"2025-03-12 14:45","pubTimestamp":1741761953,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences (GILD – Research Report) yesterday and set a price target of $120.00. T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-reaffirms-their-buy-rating-on-gilead-sciences-gild?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-reaffirms-their-buy-rating-on-gilead-sciences-gild?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GILD"],"gpt_icon":0},{"id":"2518704988","title":"These 3 Attractive Stocks Keep Cruising Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2518704988","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518704988?lang=en_us&edition=fundamental","pubTime":"2025-03-12 05:47","pubTimestamp":1741729620,"startTime":"0","endTime":"0","summary":"The market has thrown a tantrum over recent weeks, with tariff talks and other potential economic implications shaking sentiment.But despite the negativity, several stocks, including Verizon Communications VZ, Gilead Sciences GILD, and Alibaba BABA, have shaken off the woes, showing stability and relative strength throughout the period.For those interested in momentum, let’s take a closer look at each.Gilead Sciences’ latest set of quarterly results came in nicely above expectations, with the company exceeding both Zacks Consensus EPS and Sales estimates by 14% and 7%, respectively. Solid growth was also delivered, with earnings up 11% alongside a 6% sales bump.Importantly, the company’s offerings continue to generate strong demand, with total product sales of $7.5 billion exceeding our consensus expectations on the metric in seven consecutive periods.As shown below, the beats have regularly been outsized as of late, undoubtedly a positive trajectory.Importantly, its AI-related product","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-attractive-stocks-keep-cruising-214700683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4527","IE00B7SZLL34.SGD","LU0306806265.USD","BK4566","LU1059921491.USD","BK4515","IE00BSNM7G36.USD","BK4533","BK4583","LU0501845795.SGD","GILD","BK4581","LU0320765992.SGD","LU1699723380.USD","IE00BZ1G4Q59.USD","LU0918141705.HKD","BK4575","BK4550","BK4534","LU1839511570.USD","LU0321505439.SGD","IE00B0JY6N72.USD","LU0109394709.USD","LU0306807586.USD","HBBD.SI","LU1066053197.SGD","LU0868494617.USD","LU1267930227.SGD","LU1621768206.USD","BK4526","BK4532","09988","LU0348814723.USD","VZ","LU0251143458.SGD","BK4588","LU0128525689.USD","LU0310800965.SGD","LU1621768115.EUR","LU1571399168.USD","IE0002270589.USD","BABA","LU1621767737.EUR","LU2384288077.EUR","BK4614","LU1688375341.USD","LU0868494708.USD","BK4554","BK4585","LU0072913022.USD","LU0225284248.USD"],"gpt_icon":1},{"id":"2518778375","title":"Gilead Sciences Once-yearly HIV Prevention Treatment Safe, Well Tolerated in Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518778375","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518778375?lang=en_us&edition=fundamental","pubTime":"2025-03-12 02:07","pubTimestamp":1741716420,"startTime":"0","endTime":"0","summary":"Gilead Sciences  said Tuesday that two different once-yearly formulations of lenacapavir for HIV prevention were found to be safe and well tolerated in an ongoing study.The company said it presented the first data from its ongoing phase 1 study of the formulations at a medical conference and also published the results in The Lancet.The data showed that the formulations reached and maintained blood levels above those associated with preventing HIV in earlier phase 3 trials that studied a twice-yearly version of lenacapavir.The data will support the future development of once-yearly lenacapavir, for which Gilead plans to launch a phase 3 study in H2, the company said.Gilead shares were down 2% in recent trading.Price: 114.77, Change: -2.44, Percent Change: -2.08","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4566","LU0234570918.USD","BK4583","BK4139","IE0002270589.USD","LU0109394709.USD","LU1066053197.SGD","LU1430594728.SGD","BK4532","LU1066051498.USD","LU0058720904.USD","BK4585","LU0889565916.HKD","BK4550","LU1839511570.USD","IE00BZ1G4Q59.USD","LU2468319806.SGD","IE00B3T34201.USD","LU1585245621.USD","IE00B19Z3581.USD","LU1571399168.USD","GILD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4588","LU0320765992.SGD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU2089984988.USD","BK4568","LU2087621335.USD","IE00B7SZLL34.SGD","BK4578"],"gpt_icon":0},{"id":"2518477984","title":"NVO Stock Down 9% as CagriSema Misses Target in Second Obesity Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518477984","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518477984?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:51","pubTimestamp":1741715460,"startTime":"0","endTime":"0","summary":"Novo Nordisk NVO has achieved the primary endpoint in the second late-stage study evaluating its next-gen subcutaneous obesity treatment candidate, CagriSema, in patients with obesity and type 2 diabetes  and a mean baseline body weight of 102 kg. The results showed that treatment with the candidate led to a statistically significant and superior weight loss at week 68compared with placebo.NVO’s CagriSema is a fixed-dose combination of a long-acting amylin analogue, cagrilintide 2.4 mg and Wegovy. The two molecules promote weight loss by suppressing hunger, enhancing feelings of fullness and helping individuals consume fewer calories.The phase III REDEFINE 2 study followed a flexible protocol, enabling patients to adjust their dosing throughout the study. After 68 weeks, 61.9% of those treated with CagriSema reached the highest dose.Novo Nordisk plans to submit a regulatory application seeking the first approval for CagriSema for the obesity indication in the first quarter of 2026. Det","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nvo-stock-down-9-cagrisema-175100065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2087621335.USD","IE00B7SZLL34.SGD","BMRN","LU0154236417.USD","LU0058720904.USD","LU2089984988.USD","BK4139","CORT","IE00B19Z3B42.SGD","BK4007","BK4550","BK4588","IE00BZ1G4Q59.USD","BK4578","GILD","LU0320765992.SGD","LU1559883803.SGD","LU1585245621.USD","NVO","BK4585","BK4568","BK4583","LU0234570918.USD","LU1066053197.SGD","LU1093756325.SGD","LU1430594728.SGD","LU1066051498.USD","LU1093756168.USD","IE00BKVL7J92.USD","LU0109394709.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU1839511570.USD","BK4532","BK4566","LU0566484027.USD","BK4599","LU0289739699.SGD","LU1571399168.USD","IE00B19Z3581.USD","LU2468319806.SGD","LU0889565916.HKD","IE0002270589.USD"],"gpt_icon":1},{"id":"2518727753","title":"BRIEF-Gilead Sciences Presents First Clinical Data For Investigational Once-Yearly Lenacapavir For HIV Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2518727753","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518727753?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:37","pubTimestamp":1741714624,"startTime":"0","endTime":"0","summary":"BRIEF-Gilead Sciences Presents First Clinical Data For Investigational Once-Yearly Lenacapavir For HIV PreventionMarch 11  - Gilead Sciences Inc GILD.O:GILEAD SCIENCES PRESENTS FIRST CLINICAL DATA FOR INVESTIGATIONAL ONCE-YEARLY LENACAPAVIR FOR HIV PREVENTIONGILEAD SCIENCES: DATA SHOWS PROMISING ONCE-YEARLY LENACAPAVIR FOR PREP PHARMACOKINETIC PROFILES OVER 52 WEEKSGILEAD SCIENCES: SAFETY DATA SHOWED BOTH FORMULATIONS OF ONCE-YEARLY LENACAPAVIR FOR PREP WERE WELL TOLERATED, WITH NO NEW SAFETY SIGNALSGILEAD SCIENCES: NEW PREP MODALITY PREFERENCE DATA SHOWS PREFERENCE FOR TWICE-YEARLY LENACAPAVIR VERSUS ONCE DAILY ORALS IN PURPOSE 1 SURVEY PARTICIPANTSGILEAD SCIENCES: NEW STUDY POPULATION DATA FROM PURPOSE 1 SHOW COMPARABLE PHARMACOKINETIC & SAFETY PROFILES FOR ADOLESCENT & ADULT TRIAL PARTICIPANTSSource text: [ID:]Further company coverage: GILD.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nP8N3M007C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU0058720904.USD","LU0889565916.HKD","LU2468319806.SGD","IE00B7SZLL34.SGD","LU2087621335.USD","BK4585","LU0320765992.SGD","BK4578","GILD","BK4588","LU1585245621.USD","BK4566","LU1571399168.USD","BK4139","LU2089984988.USD","IE0002270589.USD","BK4532","LU0234570918.USD","BK4568","BK4583","IE00B19Z3581.USD","LU0109394709.USD","LU1839511570.USD","LU1066053197.SGD","LU1430594728.SGD","BK4550","IE00BZ1G4Q59.USD","LU1066051498.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0289739699.SGD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2518972714","title":"Gilead Sciences: Data Shows Promising Once-Yearly Lenacapavir for Prep Pharmacokinetic Profiles Over 52 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2518972714","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518972714?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:37","pubTimestamp":1741714620,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nP8N3M007C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z3581.USD","LU1571399168.USD","IE00BKVL7J92.USD","BK4585","LU1430594728.SGD","BK4568","LU0058720904.USD","BK4550","IE00B19Z3B42.SGD","LU1066053197.SGD","GILD","LU1066051498.USD","IE00BSNM7G36.USD","BK4532","LU0234570918.USD","LU1839511570.USD","IE00B3T34201.USD","BK4583","BK4566","LU2087621335.USD","LU1585245621.USD","IE0002270589.USD","LU0109394709.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","BK4139","LU2089984988.USD","LU2468319806.SGD","IE00B7SZLL34.SGD","LU0289739699.SGD","BK4578","LU0889565916.HKD","BK4588"],"gpt_icon":0},{"id":"2518727145","title":"Gilead Sciences: New Study Population Data From Purpose 1 Show Comparable Pharmacokinetic & Safety Profilesfor Adolescent & Adult Trial Participants","url":"https://stock-news.laohu8.com/highlight/detail?id=2518727145","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518727145?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:37","pubTimestamp":1741714620,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nP8N3M007C:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0058720904.USD","BK4583","LU2468319806.SGD","IE00BSNM7G36.USD","LU1066053197.SGD","IE00B3T34201.USD","LU0889565916.HKD","IE00BKVL7J92.USD","LU1066051498.USD","LU1430594728.SGD","BK4532","BK4139","BK4568","LU0234570918.USD","LU2089984988.USD","IE0002270589.USD","GILD","BK4585","LU0109394709.USD","IE00B19Z3581.USD","BK4578","LU0289739699.SGD","LU1585245621.USD","BK4588","LU1839511570.USD","IE00B19Z3B42.SGD","BK4566","IE00B7SZLL34.SGD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","BK4550","LU0320765992.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GILD\",params:#limit:5,,,undefined,":[{"date":"2025-04-24","symbol":"GILD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.75,"defaultRemindTime":1745524800000,"name":null,"time":"Post Market","dateTimestamp":1745467200000,"actualEps":null},{"date":"2025-03-14","symbol":"GILD","amount":0.79,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-14","defaultRemindTime":1741959000000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-14","currency":"USD","dateTimestamp":1741924800000,"payDate":"2025-03-28"},{"market":"US","date":"2025-02-11","symbol":"GILD","fiscalQuarterEnding":"2024/12","expectedEps":1.67,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":1.9},{"date":"2024-12-13","symbol":"GILD","amount":0.77,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-30"},{"market":"US","date":"2024-11-06","symbol":"GILD","fiscalQuarterEnding":"2024/09","expectedEps":1.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":2.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GILD\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-12","recordDate":"2015-06-16","paymentDate":"2015-06-29","value":0.43,"currency":"USD"},{"executeDate":"2015-09-14","recordDate":"2015-09-16","paymentDate":"2015-09-29","value":0.43,"currency":"USD"},{"executeDate":"2015-12-14","recordDate":"2015-12-16","paymentDate":"2015-12-30","value":0.43,"currency":"USD"},{"executeDate":"2016-03-14","recordDate":"2016-03-16","paymentDate":"2016-03-30","value":0.43,"currency":"USD"},{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-29","value":0.47,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GILD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.3333,"hold":0.3667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":30,"updateTime":1742443200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GILD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GILD","date":"2025-04-22","current":270.961196,"percent":0.817143,"low":-353.030459,"twenty":16.17325,"median":19.270108,"eighty":174.419449,"high":985.638037,"avg":115.654755,"sd":257.282824,"marketCap":130061374150},"quantilePoints":[{"date":"2020-04-24","current":18.616407,"twenty":6.427197,"median":14.646819,"eighty":30.203766,"marketCap":100267968138},{"date":"2020-05-01","current":20.205018,"twenty":6.427197,"median":14.646819,"eighty":30.040279,"marketCap":100257300000},{"date":"2020-05-08","current":19.589157,"twenty":6.427197,"median":14.646819,"eighty":29.863518,"marketCap":97201394766},{"date":"2020-05-15","current":19.278218,"twenty":6.427197,"median":14.646819,"eighty":29.6922,"marketCap":95658515484},{"date":"2020-05-22","current":18.540053,"twenty":6.427197,"median":14.646819,"eighty":29.202205,"marketCap":91995745156},{"date":"2020-05-29","current":19.675107,"twenty":6.427197,"median":14.646819,"eighty":29.042662,"marketCap":97627881722},{"date":"2020-06-05","current":19.402088,"twenty":6.427197,"median":14.646819,"eighty":28.831708,"marketCap":96273158450},{"date":"2020-06-12","current":18.504662,"twenty":6.427197,"median":14.646819,"eighty":27.315326,"marketCap":91820132880},{"date":"2020-06-19","current":19.584101,"twenty":6.427197,"median":14.646819,"eighty":26.917351,"marketCap":97176307298},{"date":"2020-06-26","current":18.850992,"twenty":6.427197,"median":14.646819,"eighty":26.756696,"marketCap":93538624438},{"date":"2020-07-02","current":19.300969,"twenty":6.427197,"median":14.646819,"eighty":26.63808,"marketCap":95771409090},{"date":"2020-07-10","current":19.293385,"twenty":6.427197,"median":14.646819,"eighty":26.355806,"marketCap":95733777888},{"date":"2020-07-17","current":19.594212,"twenty":6.427197,"median":14.646819,"eighty":25.598322,"marketCap":97226482234},{"date":"2020-07-24","current":18.615892,"twenty":6.427197,"median":14.646819,"eighty":25.376857,"marketCap":92372057176},{"date":"2020-07-31","current":-339.364134,"twenty":6.410323,"median":14.629784,"eighty":25.277011,"marketCap":87216582502},{"date":"2020-08-07","current":-338.310448,"twenty":6.392142,"median":14.560725,"eighty":25.150137,"marketCap":86945785059},{"date":"2020-08-14","current":-334.163889,"twenty":6.380126,"median":14.488429,"eighty":25.150137,"marketCap":85880119345},{"date":"2020-08-21","current":-324.407279,"twenty":6.34887,"median":14.451741,"eighty":25.150137,"marketCap":83372670605},{"date":"2020-08-28","current":-318.35818,"twenty":6.326168,"median":14.415069,"eighty":25.150137,"marketCap":81818052386},{"date":"2020-09-04","current":-322.016909,"twenty":6.300695,"median":14.353547,"eighty":25.150137,"marketCap":82758345663},{"date":"2020-09-11","current":-319.919238,"twenty":6.282152,"median":14.321176,"eighty":25.150137,"marketCap":82219244184},{"date":"2020-09-18","current":-317.333736,"twenty":6.244206,"median":14.279358,"eighty":25.150137,"marketCap":81554770268},{"date":"2020-09-25","current":-303.674483,"twenty":6.163333,"median":14.261828,"eighty":25.150137,"marketCap":78044342032},{"date":"2020-10-02","current":-303.284218,"twenty":6.038611,"median":14.169569,"eighty":25.150137,"marketCap":77944044082},{"date":"2020-10-09","current":-311.430987,"twenty":5.952564,"median":14.135621,"eighty":25.150137,"marketCap":80037763780},{"date":"2020-10-16","current":-302.454906,"twenty":5.912527,"median":14.104836,"eighty":25.150137,"marketCap":77730910940},{"date":"2020-10-23","current":-296.552157,"twenty":5.894484,"median":14.057828,"eighty":25.150137,"marketCap":76213904452},{"date":"2020-10-30","current":57.495325,"twenty":5.887283,"median":14.035041,"eighty":25.277011,"marketCap":72904072115},{"date":"2020-11-06","current":58.395826,"twenty":5.887283,"median":14.035041,"eighty":25.376857,"marketCap":74045907761},{"date":"2020-11-13","current":59.893535,"twenty":5.887283,"median":14.035041,"eighty":25.598322,"marketCap":75945002907},{"date":"2020-11-20","current":59.423957,"twenty":5.887283,"median":14.035041,"eighty":26.355806,"marketCap":75349577036},{"date":"2020-11-27","current":59.34487,"twenty":5.887283,"median":14.035041,"eighty":26.598291,"marketCap":75249294784},{"date":"2020-12-04","current":60.857408,"twenty":5.887283,"median":14.035041,"eighty":26.756696,"marketCap":77167192852},{"date":"2020-12-11","current":60.066538,"twenty":5.887283,"median":14.035041,"eighty":26.917351,"marketCap":76164370333},{"date":"2020-12-18","current":58.405712,"twenty":5.887283,"median":14.035041,"eighty":27.315326,"marketCap":74058443042},{"date":"2020-12-24","current":56.418653,"twenty":5.887283,"median":14.035041,"eighty":28.776154,"marketCap":71538851463},{"date":"2020-12-31","current":57.595071,"twenty":5.887283,"median":14.035041,"eighty":28.982603,"marketCap":73030549960},{"date":"2021-01-08","current":62.320516,"twenty":5.887283,"median":14.035041,"eighty":29.131999,"marketCap":79022414512},{"date":"2021-01-15","current":62.607206,"twenty":5.887283,"median":14.035041,"eighty":29.690755,"marketCap":79385937676},{"date":"2021-01-22","current":66.176005,"twenty":5.887283,"median":14.071576,"eighty":29.782104,"marketCap":83911174294},{"date":"2021-01-29","current":64.851299,"twenty":5.887283,"median":14.109654,"eighty":29.979206,"marketCap":82231446574},{"date":"2021-02-05","current":697.695423,"twenty":5.887283,"median":14.148779,"eighty":30.122962,"marketCap":85816537080},{"date":"2021-02-12","current":681.695105,"twenty":5.887283,"median":14.235931,"eighty":30.220678,"marketCap":83848497886},{"date":"2021-02-19","current":656.013065,"twenty":5.887283,"median":14.27046,"eighty":30.484701,"marketCap":80689606951},{"date":"2021-02-26","current":627.274958,"twenty":5.887283,"median":14.306069,"eighty":30.569263,"marketCap":77154819778},{"date":"2021-03-05","current":660.171136,"twenty":5.886815,"median":14.351389,"eighty":30.669098,"marketCap":81201049740},{"date":"2021-03-12","current":628.90955,"twenty":5.886815,"median":14.411816,"eighty":30.847379,"marketCap":77355874683},{"date":"2021-03-19","current":658.536543,"twenty":5.886815,"median":14.446346,"eighty":30.947914,"marketCap":80999994835},{"date":"2021-03-26","current":666.505183,"twenty":5.887283,"median":14.479757,"eighty":31.062543,"marketCap":81980137497},{"date":"2021-04-01","current":680.094988,"twenty":5.887283,"median":14.515798,"eighty":31.220392,"marketCap":83651683496},{"date":"2021-04-09","current":666.480805,"twenty":5.886815,"median":14.621022,"eighty":31.471261,"marketCap":81977138959},{"date":"2021-04-16","current":684.496566,"twenty":5.886815,"median":14.653082,"eighty":31.596225,"marketCap":84193077595},{"date":"2021-04-23","current":670.268209,"twenty":5.886815,"median":14.712213,"eighty":42.207393,"marketCap":82442989695},{"date":"2021-04-30","current":265.489326,"twenty":5.886815,"median":14.778694,"eighty":42.567879,"marketCap":79912287049},{"date":"2021-05-07","current":277.252542,"twenty":5.886815,"median":14.856386,"eighty":42.894314,"marketCap":83453015165},{"date":"2021-05-14","current":285.544285,"twenty":5.886815,"median":14.904321,"eighty":43.205482,"marketCap":85948829715},{"date":"2021-05-21","current":286.46096,"twenty":5.886815,"median":15.044244,"eighty":43.463811,"marketCap":86224748912},{"date":"2021-05-28","current":275.460859,"twenty":5.886815,"median":15.158818,"eighty":43.913538,"marketCap":82913718554},{"date":"2021-06-04","current":280.960909,"twenty":5.886815,"median":15.193582,"eighty":44.006301,"marketCap":84569233733},{"date":"2021-06-11","current":286.544294,"twenty":5.886815,"median":15.256684,"eighty":44.397317,"marketCap":86249832475},{"date":"2021-06-18","current":277.544211,"twenty":5.886815,"median":15.331847,"eighty":44.793017,"marketCap":83540807637},{"date":"2021-06-25","current":282.835927,"twenty":5.886815,"median":15.396911,"eighty":44.953898,"marketCap":85133613908},{"date":"2021-07-02","current":288.752648,"twenty":5.886815,"median":15.472548,"eighty":45.316733,"marketCap":86914546903},{"date":"2021-07-09","current":284.252606,"twenty":5.886815,"median":15.579206,"eighty":45.697022,"marketCap":85560034484},{"date":"2021-07-16","current":285.960955,"twenty":5.886815,"median":15.726234,"eighty":45.841484,"marketCap":86074247532},{"date":"2021-07-23","current":287.58597,"twenty":5.886815,"median":15.752152,"eighty":47.568365,"marketCap":86563377017},{"date":"2021-07-30","current":16.591985,"twenty":5.886815,"median":15.856378,"eighty":51.009533,"marketCap":85647826956},{"date":"2021-08-06","current":16.706124,"twenty":5.886815,"median":15.9165,"eighty":51.009533,"marketCap":86237013283},{"date":"2021-08-13","current":17.284208,"twenty":5.886815,"median":16.177233,"eighty":51.009533,"marketCap":89221079750},{"date":"2021-08-20","current":17.59511,"twenty":5.886815,"median":16.446515,"eighty":51.009533,"marketCap":90825955833},{"date":"2021-08-27","current":17.313355,"twenty":5.886815,"median":16.628399,"eighty":51.009533,"marketCap":89371536883},{"date":"2021-09-03","current":17.478521,"twenty":5.886815,"median":16.94972,"eighty":51.009533,"marketCap":90224127302},{"date":"2021-09-10","current":17.242916,"twenty":5.886815,"median":16.972053,"eighty":51.009533,"marketCap":89007932145},{"date":"2021-09-17","current":17.393509,"twenty":5.886815,"median":17.123861,"eighty":51.009533,"marketCap":89785293998},{"date":"2021-09-24","current":17.291494,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":89258694033},{"date":"2021-10-01","current":16.652688,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85961175206},{"date":"2021-10-08","current":16.528813,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85321732392},{"date":"2021-10-15","current":16.426798,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84795132427},{"date":"2021-10-22","current":16.33207,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84306146745},{"date":"2021-10-29","current":11.012226,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":81424400000},{"date":"2021-11-05","current":11.251111,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":83190715179},{"date":"2021-11-12","current":11.447904,"twenty":5.893685,"median":17.235629,"eighty":51.009533,"marketCap":84645800064},{"date":"2021-11-19","current":11.653179,"twenty":5.897479,"median":17.235629,"eighty":51.009533,"marketCap":86163604126},{"date":"2021-11-26","current":11.921224,"twenty":5.918211,"median":17.235629,"eighty":51.009533,"marketCap":88145530090},{"date":"2021-12-03","current":11.800773,"twenty":6.026147,"median":17.235629,"eighty":51.009533,"marketCap":87254917790},{"date":"2021-12-10","current":11.917831,"twenty":6.210409,"median":17.235629,"eighty":51.009533,"marketCap":88120442420},{"date":"2021-12-17","current":12.250343,"twenty":6.275567,"median":17.235629,"eighty":51.009533,"marketCap":90579034123},{"date":"2021-12-23","current":12.296148,"twenty":6.286831,"median":17.235629,"eighty":51.009533,"marketCap":90917717674},{"date":"2021-12-31","current":12.318202,"twenty":6.311092,"median":17.235629,"eighty":51.009533,"marketCap":91080787532},{"date":"2022-01-07","current":12.089176,"twenty":6.331714,"median":17.2332,"eighty":50.998121,"marketCap":89387369777},{"date":"2022-01-14","current":12.175697,"twenty":6.376154,"median":17.2332,"eighty":50.998121,"marketCap":90027105373},{"date":"2022-01-21","current":11.622642,"twenty":6.392142,"median":17.2332,"eighty":50.998121,"marketCap":85937815092},{"date":"2022-01-28","current":11.682019,"twenty":6.427197,"median":17.2332,"eighty":50.998121,"marketCap":86376849324},{"date":"2022-02-04","current":12.876322,"twenty":6.478068,"median":17.2332,"eighty":50.998121,"marketCap":80155107055},{"date":"2022-02-11","current":12.507564,"twenty":6.506803,"median":17.2332,"eighty":50.998121,"marketCap":77859585210},{"date":"2022-02-18","current":12.302026,"twenty":6.55983,"median":17.2332,"eighty":50.998121,"marketCap":76580114018},{"date":"2022-02-25","current":12.311254,"twenty":6.578904,"median":17.2332,"eighty":50.998121,"marketCap":76637556570},{"date":"2022-03-04","current":12.46031,"twenty":6.599937,"median":17.2332,"eighty":50.998121,"marketCap":77565432746},{"date":"2022-03-11","current":11.6828,"twenty":6.635114,"median":17.2332,"eighty":50.998121,"marketCap":72725429992},{"date":"2022-03-18","current":11.968827,"twenty":6.678391,"median":17.2332,"eighty":50.998121,"marketCap":74505949140},{"date":"2022-03-25","current":11.884082,"twenty":6.698205,"median":17.2332,"eighty":50.998121,"marketCap":73978409872},{"date":"2022-04-01","current":12.037399,"twenty":8.02258,"median":17.2332,"eighty":50.998121,"marketCap":74932807962},{"date":"2022-04-08","current":12.567956,"twenty":8.716567,"median":17.2332,"eighty":50.998121,"marketCap":78235527670},{"date":"2022-04-14","current":12.471124,"twenty":8.90123,"median":17.2332,"eighty":50.998121,"marketCap":77632749929},{"date":"2022-04-22","current":12.55787,"twenty":9.141519,"median":17.2332,"eighty":50.998121,"marketCap":78172738322},{"date":"2022-04-29","current":16.504629,"twenty":9.361538,"median":17.2332,"eighty":50.998121,"marketCap":74518398265},{"date":"2022-05-06","current":16.996433,"twenty":10.809551,"median":17.239272,"eighty":50.998121,"marketCap":76738896748},{"date":"2022-05-13","current":17.327028,"twenty":11.245343,"median":17.247681,"eighty":50.998121,"marketCap":78231529751},{"date":"2022-05-20","current":17.735409,"twenty":11.419063,"median":17.289789,"eighty":50.998121,"marketCap":80075370520},{"date":"2022-05-27","current":18.002107,"twenty":11.443493,"median":17.319427,"eighty":50.998121,"marketCap":81279511430},{"date":"2022-06-03","current":17.627063,"twenty":11.598891,"median":17.34736,"eighty":50.998121,"marketCap":79586188275},{"date":"2022-06-10","current":16.874197,"twenty":11.674743,"median":17.353688,"eighty":50.998121,"marketCap":76186998831},{"date":"2022-06-17","current":16.260236,"twenty":11.693895,"median":17.353688,"eighty":50.998121,"marketCap":73414966111},{"date":"2022-06-24","current":17.524273,"twenty":11.796701,"median":17.385368,"eighty":51.009533,"marketCap":79122092299},{"date":"2022-07-01","current":17.32425,"twenty":11.863803,"median":17.393509,"eighty":51.009533,"marketCap":78218986617},{"date":"2022-07-08","current":17.457598,"twenty":11.905616,"median":17.41294,"eighty":51.009533,"marketCap":78821057072},{"date":"2022-07-15","current":17.390924,"twenty":11.935322,"median":17.41294,"eighty":51.009533,"marketCap":78520021844},{"date":"2022-07-22","current":16.890865,"twenty":11.980941,"median":17.41294,"eighty":51.009533,"marketCap":76262257638},{"date":"2022-07-29","current":16.599165,"twenty":12.028097,"median":17.41294,"eighty":51.009533,"marketCap":74945228518},{"date":"2022-08-05","current":18.52212,"twenty":12.086156,"median":17.427039,"eighty":51.009533,"marketCap":76626008538},{"date":"2022-08-12","current":19.074694,"twenty":12.171909,"median":17.456661,"eighty":51.009533,"marketCap":78912011126},{"date":"2022-08-19","current":19.795752,"twenty":12.222347,"median":17.478521,"eighty":51.009533,"marketCap":81895025523},{"date":"2022-08-26","current":18.895945,"twenty":12.254415,"median":17.529437,"eighty":51.009533,"marketCap":78172524363},{"date":"2022-09-02","current":19.335245,"twenty":12.287819,"median":17.577057,"eighty":51.009533,"marketCap":79989907085},{"date":"2022-09-09","current":19.777574,"twenty":12.303022,"median":17.627063,"eighty":51.009533,"marketCap":81819823480},{"date":"2022-09-16","current":19.874523,"twenty":12.328536,"median":17.735409,"eighty":51.009533,"marketCap":82220901046},{"date":"2022-09-23","current":19.044398,"twenty":12.37249,"median":17.877092,"eighty":51.009533,"marketCap":78786674386},{"date":"2022-09-30","current":18.689929,"twenty":12.440381,"median":18.002107,"eighty":51.009533,"marketCap":77320234535},{"date":"2022-10-07","current":19.477638,"twenty":12.472434,"median":18.174606,"eighty":51.009533,"marketCap":80578989760},{"date":"2022-10-14","current":20.047213,"twenty":12.542538,"median":18.389663,"eighty":51.009533,"marketCap":82935320460},{"date":"2022-10-21","current":20.538017,"twenty":12.806741,"median":18.504662,"eighty":51.009533,"marketCap":84965775639},{"date":"2022-10-28","current":29.80037,"twenty":13.013399,"median":18.615892,"eighty":51.009533,"marketCap":99354433322},{"date":"2022-11-04","current":30.22374,"twenty":13.251735,"median":18.662662,"eighty":51.009533,"marketCap":100765950507},{"date":"2022-11-11","current":30.780513,"twenty":13.37445,"median":18.717011,"eighty":51.009533,"marketCap":102622231397},{"date":"2022-11-18","current":31.45767,"twenty":13.431735,"median":18.843409,"eighty":51.009533,"marketCap":104879870318},{"date":"2022-11-25","current":32.450832,"twenty":13.459519,"median":18.879888,"eighty":51.009533,"marketCap":108191074069},{"date":"2022-12-02","current":33.4929,"twenty":13.504605,"median":18.899024,"eighty":51.009533,"marketCap":111665329520},{"date":"2022-12-09","current":33.09413,"twenty":13.606687,"median":18.972334,"eighty":51.009533,"marketCap":110335831044},{"date":"2022-12-16","current":32.638931,"twenty":13.64752,"median":19.040589,"eighty":51.009533,"marketCap":108818195992},{"date":"2022-12-23","current":31.882773,"twenty":13.702003,"median":19.108021,"eighty":51.009533,"marketCap":106297165863},{"date":"2022-12-30","current":32.296591,"twenty":13.772637,"median":19.194795,"eighty":51.009533,"marketCap":107676834093},{"date":"2023-01-06","current":33.135512,"twenty":13.805022,"median":19.238296,"eighty":51.009533,"marketCap":110473797867},{"date":"2023-01-13","current":32.454594,"twenty":13.873802,"median":19.29283,"eighty":51.009533,"marketCap":108203616508},{"date":"2023-01-20","current":31.228189,"twenty":13.90331,"median":19.320096,"eighty":51.009533,"marketCap":104114781573},{"date":"2023-01-27","current":31.499051,"twenty":13.995449,"median":19.384392,"eighty":51.009533,"marketCap":105017837141},{"date":"2023-02-03","current":22.946755,"twenty":14.041486,"median":19.450119,"eighty":51.009533,"marketCap":105371500000},{"date":"2023-02-10","current":23.544186,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":108114900000},{"date":"2023-02-17","current":23.017361,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105695720000},{"date":"2023-02-24","current":21.905815,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":100591501721},{"date":"2023-03-03","current":22.017164,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":101102814834},{"date":"2023-03-10","current":21.59078,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99144859743},{"date":"2023-03-17","current":20.996015,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":96413699455},{"date":"2023-03-24","current":21.756377,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99905284240},{"date":"2023-03-31","current":22.564083,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":103614267917},{"date":"2023-04-06","current":22.749012,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":104463462833},{"date":"2023-04-14","current":22.645669,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":103988912733},{"date":"2023-04-21","current":23.031845,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105762231528},{"date":"2023-04-28","current":18.688623,"twenty":14.055938,"median":19.442338,"eighty":51.020944,"marketCap":104338581228},{"date":"2023-05-05","current":17.542922,"twenty":14.055938,"median":19.3806,"eighty":51.020944,"marketCap":97942133140},{"date":"2023-05-12","current":17.583137,"twenty":14.055938,"median":19.319381,"eighty":51.020944,"marketCap":98166656624},{"date":"2023-05-19","current":17.473662,"twenty":14.050438,"median":19.278218,"eighty":51.032356,"marketCap":97555453806},{"date":"2023-05-26","current":17.348547,"twenty":14.044939,"median":19.233751,"eighty":51.043768,"marketCap":96856936300},{"date":"2023-06-02","current":17.026822,"twenty":14.044939,"median":19.162011,"eighty":51.043768,"marketCap":95060748428},{"date":"2023-06-08","current":16.997778,"twenty":14.044939,"median":19.104641,"eighty":51.043768,"marketCap":94898592579},{"date":"2023-06-16","current":17.650163,"twenty":14.039759,"median":19.040589,"eighty":51.200274,"marketCap":98540862431},{"date":"2023-06-23","current":17.45132,"twenty":14.038033,"median":18.973525,"eighty":51.252442,"marketCap":97430718537},{"date":"2023-06-30","current":16.982138,"twenty":14.036306,"median":18.920182,"eighty":51.304611,"marketCap":94811277890},{"date":"2023-07-07","current":17.033525,"twenty":14.036306,"median":18.886384,"eighty":51.304611,"marketCap":95098169009},{"date":"2023-07-14","current":17.138532,"twenty":14.036306,"median":18.848464,"eighty":51.304611,"marketCap":95684424773},{"date":"2023-07-21","current":17.860178,"twenty":14.036306,"median":18.770739,"eighty":51.304611,"marketCap":99713373958},{"date":"2023-07-28","current":17.093848,"twenty":14.036306,"median":18.679091,"eighty":51.304611,"marketCap":95434954235},{"date":"2023-08-04","current":17.179531,"twenty":14.036306,"median":18.633127,"eighty":51.304611,"marketCap":94212548600},{"date":"2023-08-11","current":18.176723,"twenty":14.036306,"median":18.52212,"eighty":51.304611,"marketCap":99681148240},{"date":"2023-08-18","current":17.381491,"twenty":14.036306,"median":18.429012,"eighty":51.304611,"marketCap":95320098004},{"date":"2023-08-25","current":17.342866,"twenty":14.036306,"median":18.328953,"eighty":51.304611,"marketCap":95108275564},{"date":"2023-09-01","current":17.376947,"twenty":14.036306,"median":18.1949,"eighty":51.304611,"marketCap":95295177717},{"date":"2023-09-08","current":16.799836,"twenty":14.036306,"median":18.174606,"eighty":51.304611,"marketCap":92130301260},{"date":"2023-09-15","current":17.576891,"twenty":14.036306,"median":18.052169,"eighty":51.304611,"marketCap":96391670348},{"date":"2023-09-22","current":17.102024,"twenty":14.036306,"median":17.993772,"eighty":51.304611,"marketCap":93787500350},{"date":"2023-09-29","current":17.136105,"twenty":14.036306,"median":17.876807,"eighty":51.304611,"marketCap":93974402503},{"date":"2023-10-06","current":16.972515,"twenty":14.036306,"median":17.771527,"eighty":51.304611,"marketCap":93077272169},{"date":"2023-10-13","current":17.440566,"twenty":14.036306,"median":17.722305,"eighty":51.304611,"marketCap":95644061736},{"date":"2023-10-19","current":18.101744,"twenty":14.036306,"median":17.689975,"eighty":51.304611,"marketCap":99269963503},{"date":"2023-10-27","current":17.835909,"twenty":14.029482,"median":17.676863,"eighty":51.032356,"marketCap":97812126710},{"date":"2023-11-03","current":18.45619,"twenty":14.029482,"median":17.650163,"eighty":33.471833,"marketCap":101213745894},{"date":"2023-11-10","current":15.89997,"twenty":14.029482,"median":17.641227,"eighty":33.09714,"marketCap":93428221287},{"date":"2023-11-17","current":15.802424,"twenty":14.029482,"median":17.615533,"eighty":32.981271,"marketCap":92855042015},{"date":"2023-11-24","current":15.984792,"twenty":14.029482,"median":17.59511,"eighty":32.559177,"marketCap":93926638045},{"date":"2023-12-01","current":16.243501,"twenty":14.029482,"median":17.57082,"eighty":32.289819,"marketCap":95446809157},{"date":"2023-12-08","current":16.550982,"twenty":14.031188,"median":17.55419,"eighty":32.133321,"marketCap":97253569904},{"date":"2023-12-15","current":17.341951,"twenty":14.031188,"median":17.52836,"eighty":32.07012,"marketCap":101901306173},{"date":"2023-12-22","current":16.737591,"twenty":14.031188,"median":17.504184,"eighty":31.887287,"marketCap":98350086772},{"date":"2023-12-29","current":17.206235,"twenty":14.029482,"median":17.486007,"eighty":31.764,"marketCap":101103839360},{"date":"2024-01-05","current":17.914503,"twenty":14.027776,"median":17.48476,"eighty":31.6075,"marketCap":105265619289},{"date":"2024-01-12","current":18.107474,"twenty":14.027776,"median":17.48476,"eighty":31.532333,"marketCap":106399517414},{"date":"2024-01-19","current":18.321651,"twenty":14.024373,"median":17.483513,"eighty":31.465946,"marketCap":107658019728},{"date":"2024-01-26","current":17.013264,"twenty":14.027776,"median":17.475784,"eighty":31.443073,"marketCap":99969941235},{"date":"2024-02-02","current":16.574308,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":97390634513},{"date":"2024-02-09","current":16.232638,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91957891851},{"date":"2024-02-16","current":16.138057,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91422093836},{"date":"2024-02-23","current":16.008284,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":90686929118},{"date":"2024-03-01","current":15.855313,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":89820349813},{"date":"2024-03-08","current":16.198369,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91763758214},{"date":"2024-03-15","current":16.319318,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":92448934253},{"date":"2024-03-22","current":16.073021,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91053666683},{"date":"2024-03-28","current":16.055429,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":90954004714},{"date":"2024-04-05","current":15.309217,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":86726715023},{"date":"2024-04-12","current":15.111111,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":85604442650},{"date":"2024-04-19","current":14.563017,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":82499489086},{"date":"2024-04-26","current":167.813786,"twenty":14.029482,"median":17.45909,"eighty":31.35376,"marketCap":81389686406},{"date":"2024-05-03","current":167.968051,"twenty":14.029482,"median":17.475896,"eighty":31.454751,"marketCap":81464504564},{"date":"2024-05-10","current":165.891135,"twenty":14.029482,"median":17.490666,"eighty":31.502061,"marketCap":80457200237},{"date":"2024-05-17","current":174.305702,"twenty":14.043532,"median":17.524273,"eighty":31.57906,"marketCap":84538265441},{"date":"2024-05-24","current":169.975478,"twenty":14.043532,"median":17.54896,"eighty":31.623197,"marketCap":82438106839},{"date":"2024-05-31","current":164.60675,"twenty":14.10774,"median":17.565264,"eighty":31.836928,"marketCap":79834273632},{"date":"2024-06-07","current":164.015933,"twenty":14.265245,"median":17.579161,"eighty":32.047548,"marketCap":79547727394},{"date":"2024-06-14","current":163.27099,"twenty":14.274228,"median":17.606597,"eighty":32.082158,"marketCap":79186429964},{"date":"2024-06-21","current":175.935023,"twenty":14.272576,"median":17.621828,"eighty":32.181475,"marketCap":85328486284},{"date":"2024-06-28","current":176.808405,"twenty":14.267619,"median":17.642004,"eighty":32.289819,"marketCap":85752076375},{"date":"2024-07-05","current":171.054361,"twenty":14.267619,"median":17.658975,"eighty":32.499738,"marketCap":82961365187},{"date":"2024-07-12","current":179.736802,"twenty":14.267619,"median":17.687689,"eighty":32.981271,"marketCap":87172349033},{"date":"2024-07-15","current":179.711114,"twenty":14.267619,"median":17.696211,"eighty":33.038453,"marketCap":87159890501},{"date":"2024-08-02","current":196.485179,"twenty":14.529265,"median":17.810595,"eighty":33.095635,"marketCap":95295311956},{"date":"2024-08-09","current":89.28743,"twenty":14.761123,"median":17.860178,"eighty":33.429699,"marketCap":94108951402},{"date":"2024-08-16","current":87.810922,"twenty":15.064446,"median":17.910429,"eighty":56.284205,"marketCap":92552711301},{"date":"2024-08-23","current":89.653604,"twenty":15.441554,"median":17.994613,"eighty":57.705461,"marketCap":94494898947},{"date":"2024-08-30","current":93.846889,"twenty":15.739388,"median":18.052169,"eighty":58.207525,"marketCap":98914620835},{"date":"2024-09-06","current":93.043668,"twenty":15.813085,"median":18.107474,"eighty":58.39978,"marketCap":98068026220},{"date":"2024-09-13","current":98.229166,"twenty":15.851395,"median":18.176723,"eighty":59.168901,"marketCap":103533541455},{"date":"2024-09-20","current":99.10326,"twenty":15.88894,"median":18.219893,"eighty":59.37255,"marketCap":104454835595},{"date":"2024-09-27","current":98.087422,"twenty":15.920691,"median":18.287258,"eighty":59.81346,"marketCap":103384142406},{"date":"2024-10-04","current":99.422185,"twenty":15.979621,"median":18.356937,"eighty":60.090264,"marketCap":104790983457},{"date":"2024-10-11","current":100.012789,"twenty":16.007608,"median":18.435741,"eighty":60.321593,"marketCap":105413479498},{"date":"2024-10-18","current":103.190235,"twenty":16.047512,"median":18.510381,"eighty":60.845545,"marketCap":108762508196},{"date":"2024-10-25","current":104.867549,"twenty":16.062334,"median":18.540053,"eighty":61.800519,"marketCap":110530396951},{"date":"2024-10-31","current":104.288758,"twenty":16.062334,"median":18.540053,"eighty":63.846895,"marketCap":109920350831},{"date":"2024-11-08","current":968.122222,"twenty":16.060766,"median":18.539019,"eighty":65.503766,"marketCap":121983400000},{"date":"2024-11-15","current":911.059905,"twenty":16.060766,"median":18.539019,"eighty":67.314857,"marketCap":114793548088},{"date":"2024-11-22","current":887.816058,"twenty":16.060766,"median":18.539019,"eighty":87.499083,"marketCap":111864823324},{"date":"2024-11-29","current":915.708675,"twenty":16.060766,"median":18.539019,"eighty":88.564531,"marketCap":115379293041},{"date":"2024-12-06","current":923.720384,"twenty":16.060766,"median":18.539019,"eighty":90.934033,"marketCap":116388768385},{"date":"2024-12-13","current":913.730475,"twenty":16.060766,"median":18.539019,"eighty":93.40748,"marketCap":115130039869},{"date":"2024-12-20","current":900.971087,"twenty":16.060766,"median":18.539019,"eighty":95.961249,"marketCap":113522356914},{"date":"2024-12-27","current":933.809203,"twenty":16.060766,"median":18.539019,"eighty":98.094509,"marketCap":117659959559},{"date":"2025-01-03","current":908.784976,"twenty":16.060766,"median":18.539019,"eighty":98.88828,"marketCap":114506906941},{"date":"2025-01-10","current":881.683639,"twenty":16.059197,"median":18.537985,"eighty":99.141058,"marketCap":111092138492},{"date":"2025-01-17","current":906.510046,"twenty":16.059197,"median":18.537985,"eighty":99.880493,"marketCap":114220265794},{"date":"2025-01-24","current":919.071615,"twenty":16.059197,"median":18.537985,"eighty":100.438024,"marketCap":115803023432},{"date":"2025-01-31","current":958.93234,"twenty":16.059197,"median":18.537985,"eighty":102.332679,"marketCap":120825474836},{"date":"2025-02-07","current":969.713529,"twenty":16.09178,"median":18.615892,"eighty":104.116302,"marketCap":122183904620},{"date":"2025-02-14","current":275.113188,"twenty":16.111578,"median":18.662662,"eighty":105.609347,"marketCap":132054330207},{"date":"2025-02-21","current":285.680484,"twenty":16.147709,"median":18.689929,"eighty":162.793199,"marketCap":137126632245},{"date":"2025-02-28","current":290.769403,"twenty":16.147709,"median":18.808017,"eighty":164.216297,"marketCap":139569313325},{"date":"2025-03-07","current":301.06241,"twenty":16.143392,"median":18.87176,"eighty":165.27463,"marketCap":144509957034},{"date":"2025-03-14","current":294.083284,"twenty":16.164977,"median":18.897485,"eighty":166.913912,"marketCap":141159976127},{"date":"2025-03-21","current":274.676641,"twenty":16.17325,"median":18.953832,"eighty":167.968051,"marketCap":131844787583},{"date":"2025-03-28","current":288.401392,"twenty":16.17325,"median":19.023685,"eighty":168.716781,"marketCap":138432668251},{"date":"2025-04-04","current":291.592591,"twenty":16.17325,"median":19.104641,"eighty":171.054361,"marketCap":139964443908},{"date":"2025-04-11","current":263.079356,"twenty":16.173436,"median":19.194795,"eighty":173.515242,"marketCap":126278090686},{"date":"2025-04-17","current":272.389631,"twenty":16.173436,"median":19.238296,"eighty":174.142022,"marketCap":130747023108},{"date":"2025-04-22","current":270.961196,"twenty":16.17325,"median":19.270108,"eighty":174.419449,"marketCap":130061374150}],"updateTime":1745465829956}}}